MLchartDataset catalogue

personalized polyepitope plasmid DNA breast cancer vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015989

A polyepitope DNA vaccine composed of a DNA plasmid encoding multiple, highly immunogenic tumor-associated antigens (TAAs) that are specifically selected after genome profiling of the patient's breast cancer cells, with potential immunostimulatory and antineoplastic activities. Upon intramuscular administration and electroporation of the personalized polyepitope plasmid DNA breast cancer vaccine, the expressed TAAs induce cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing the TAAs.

Table 1. Record
IdentifierMLC-T-ONC-015989
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015989",
  "term": "personalized polyepitope plasmid DNA breast cancer vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A polyepitope DNA vaccine composed of a DNA plasmid encoding multiple, highly immunogenic tumor-associated antigens (TAAs) that are specifically selected after genome profiling of the patient's breast cancer cells, with potential immunostimulatory and antineoplastic activities. Upon intramuscular administration and electroporation of the personalized polyepitope plasmid DNA breast cancer vaccine, the expressed TAAs induce cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing the TAAs.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/personalized-polyepitope-plasmid-dna-breast-cancer-vaccine/"
}

Record 13,029 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.